Maxcyte, Inc. SEC filings MXCT
Maxcyte, Inc. has 336 filings in SEC EDGAR's recent list, going back to Apr 14, 2004. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 16, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 27, 2024 | Dec 22, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Dec 9, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 15, 2024 | Oct 14, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 26, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 11, 2023 | Dec 10, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 30, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Apr 12, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 24, 2022 | Jan 24, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Nov 2, 2021 | Oct 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 17, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 4, 2021 | Aug 3, 2021 |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- MXCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1287098
- Former names
- MAXCYTE INC (until Sep 18, 2008)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.